206 related articles for article (PubMed ID: 27498708)
1. Elevated IL-23R Expression and Foxp3+Rorgt+ Cells in Intestinal Mucosa During Acute and Chronic Colitis.
Yang J; Xu L
Med Sci Monit; 2016 Aug; 22():2785-92. PubMed ID: 27498708
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-12 converts Foxp3+ regulatory T cells to interferon-γ-producing Foxp3+ T cells that inhibit colitis.
Feng T; Cao AT; Weaver CT; Elson CO; Cong Y
Gastroenterology; 2011 Jun; 140(7):2031-43. PubMed ID: 21419767
[TBL] [Abstract][Full Text] [Related]
3. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
[TBL] [Abstract][Full Text] [Related]
4. Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.
Yu QT; Saruta M; Avanesyan A; Fleshner PR; Banham AH; Papadakis KA
Inflamm Bowel Dis; 2007 Feb; 13(2):191-9. PubMed ID: 17206665
[TBL] [Abstract][Full Text] [Related]
5. OX40 is required for regulatory T cell-mediated control of colitis.
Griseri T; Asquith M; Thompson C; Powrie F
J Exp Med; 2010 Apr; 207(4):699-709. PubMed ID: 20368580
[TBL] [Abstract][Full Text] [Related]
6. Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease.
Eastaff-Leung N; Mabarrack N; Barbour A; Cummins A; Barry S
J Clin Immunol; 2010 Jan; 30(1):80-9. PubMed ID: 19936899
[TBL] [Abstract][Full Text] [Related]
7. Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells.
Sujino T; Kanai T; Ono Y; Mikami Y; Hayashi A; Doi T; Matsuoka K; Hisamatsu T; Takaishi H; Ogata H; Yoshimura A; Littman DR; Hibi T
Gastroenterology; 2011 Sep; 141(3):1014-23. PubMed ID: 21699791
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis.
Izcue A; Hue S; Buonocore S; Arancibia-Cárcamo CV; Ahern PP; Iwakura Y; Maloy KJ; Powrie F
Immunity; 2008 Apr; 28(4):559-70. PubMed ID: 18400195
[TBL] [Abstract][Full Text] [Related]
9. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice.
Liu B; Tonkonogy SL; Sartor RB
Gastroenterology; 2011 Aug; 141(2):653-62, 662.e1-4. PubMed ID: 21679711
[TBL] [Abstract][Full Text] [Related]
10. T-helper 17 and interleukin-17-producing lymphoid tissue inducer-like cells make different contributions to colitis in mice.
Ono Y; Kanai T; Sujino T; Nemoto Y; Kanai Y; Mikami Y; Hayashi A; Matsumoto A; Takaishi H; Ogata H; Matsuoka K; Hisamatsu T; Watanabe M; Hibi T
Gastroenterology; 2012 Nov; 143(5):1288-1297. PubMed ID: 22850180
[TBL] [Abstract][Full Text] [Related]
11. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis.
Rismo R; Olsen T; Cui G; Christiansen I; Florholmen J; Goll R
Scand J Gastroenterol; 2012 May; 47(5):538-47. PubMed ID: 22486187
[TBL] [Abstract][Full Text] [Related]
12. Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation.
Boehm F; Martin M; Kesselring R; Schiechl G; Geissler EK; Schlitt HJ; Fichtner-Feigl S
BMC Gastroenterol; 2012 Jul; 12():97. PubMed ID: 22849659
[TBL] [Abstract][Full Text] [Related]
13. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.
Rojas-López AE; Soldevila G; Meza-Pérez S; Dupont G; Ostoa-Saloma P; Wurbel MA; Ventura-Juárez J; Flores-Romo L; García-Zepeda EA
Immunobiology; 2012 Aug; 217(8):795-807. PubMed ID: 22633147
[TBL] [Abstract][Full Text] [Related]
14. IL-10 signaling in CD4+ T cells is critical for the pathogenesis of collagen-induced arthritis.
Tao J; Kamanaka M; Hao J; Hao Z; Jiang X; Craft JE; Flavell RA; Wu Z; Hong Z; Zhao L; Yin Z
Arthritis Res Ther; 2011; 13(6):R212. PubMed ID: 22192790
[TBL] [Abstract][Full Text] [Related]
15. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
[TBL] [Abstract][Full Text] [Related]
16. CD4+FoxP3+ regulatory T cells from Gαi2-/- mice are functionally active in vitro, but do not prevent colitis.
Götlind YY; Raghavan S; Bland PW; Hörnquist EH
PLoS One; 2011; 6(9):e25073. PubMed ID: 21966415
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-23 promotes Th17 differentiation by inhibiting T-bet and FoxP3 and is required for elevation of interleukin-22, but not interleukin-21, in autoimmune experimental arthritis.
Mus AM; Cornelissen F; Asmawidjaja PS; van Hamburg JP; Boon L; Hendriks RW; Lubberts E
Arthritis Rheum; 2010 Apr; 62(4):1043-50. PubMed ID: 20131264
[TBL] [Abstract][Full Text] [Related]
18. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
19. Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death.
Reardon C; Wang A; McKay DM
J Immunol; 2008 Jun; 180(12):8316-26. PubMed ID: 18523298
[TBL] [Abstract][Full Text] [Related]
20. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
Yadav M; Huang MC; Goetzl EJ
Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
